{
    "Trade/Device Name(s)": [
        "FaStep\u2122 Fentanyl Rapid Test Device (Urine)",
        "FaStep\u2122 Rapid Fentanyl Urine Test (Urine)"
    ],
    "Submitter Information": "Assure Tech. LLC.",
    "510(k) Number": "K240351",
    "Predicate Device Reference 510(k) Number(s)": [
        "K233417"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NGL"
    ],
    "Summary Letter Date": "February 2, 2024",
    "Summary Letter Received Date": "February 5, 2024",
    "Submission Date": "March 5, 2024",
    "Regulation Number(s)": [
        "21 CFR 862.3650"
    ],
    "Regulation Name(s)": [
        "Opiate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Fentanyl"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunoassay",
        "Lateral flow",
        "Competitive binding",
        "Immunochromatographic assay"
    ],
    "Methodologies": [
        "Qualitative testing",
        "Antigen-antibody immunochemistry"
    ],
    "Submission Type(s)": [
        "Test",
        "Cassette",
        "Dropper"
    ],
    "Document Summary": "FDA 510(k) summary for FaStep Fentanyl Rapid Test Device, a lateral flow immunoassay for qualitative detection of fentanyl in urine",
    "Indications for Use Summary": "Rapid visual immunoassay for the qualitative, presumptive detection of fentanyl in human urine specimens at a cut-off concentration of 1 ng/mL; for in vitro diagnostic use only",
    "fda_folder": "Toxicology"
}